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Abstract
In this work we describe BIMCV-COVID-19+ dataset, a large dataset
from Medical Imaging Databank in Valencian Region Medical ImageBank
(BIMCV) with chest X-ray images CXR (CR, DX) and computed to-
mography (CT) imaging of COVID-19+ patients along with their radio-
logical findings and locations, pathologies, radiological reports (in Span-
ish), DICOM metadata, Polymerase chain reaction (PCR), Immunoglob-
ulin G (IgG) and Immunoglobulin M (IgM) diagnostic antibody tests.
The findings are mapped onto standard Unified Medical Language Sys-
tem (UMLS) terminology and they cover a wide spectrum of thoracic
entities, contrasting with the much more reduced number of entities an-
notated in previous datasets. Images are stored in high resolution and
entities are localized with anatomical labels in a Medical Imaging Data
Structure (MIDS) format. In addition, 10 images were annotated by a
team of radiologists to include semantic segmentation of radiological find-
ings. This first iteration of the database includes 1,380 CX, 885 DX
and 163 CT studies from 1,311 COVID-19+ patients. To the best of
our knowledge, this is the largest COVID-19+ dataset of images avail-
able in an open format. The dataset can be downloaded from http:
//bimcv.cipf.es/bimcv-projects/bimcv-covid19/.
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Report: opacidades de aspecto in-
tersticioalveolar parcheadas y bilat-
erales que predominan en ambos lob-
ulos inferiores sospechosas de in-
feccion por COVID-19 . senos
costofrenicos libres .
Labels: COVID 19, alveolar pat-
tern, interstitial pattern, pneumonia
Locations: costophrenic angle, lo-
bar, bilateral, lower lobe
DICOM Fields
Study Date 20200317
Patient’s Sex M
Patient’s Birth Date 1986
Modality CR
Manufacturer GE Healthcare
...
Date Test Result
17.03.2020 PCR NEGATIVE
18.03.2020 PCR NEGATIVE
19.03.2020 IGG POSITIVE
19.03.2020 IGM POSITIVE
20.03.2020 PCR POSITIVE
· · · · · ·
Table 1: Example of an image on the dataset and its associated information.
Top left: image with the ROIs for ground glass opacities (green) and consolida-
tions (purple) as marked by a trained radiologist. Top right: radiology report
(in Spanish), radiological findings, differential diagnosis and locations as ex-
tracted using natural language processing from the radiology report. Bottom
left: example of the image metadata as obtained from the DICOM fields. Bot-
tom right: diagnostic tests performed to this subject, showing positive results
for IGG and IGM on 19/03/2020 and positive in PCR on 20/03/2020.
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Background & Summary
SARS-Cov-2 has created an unprecedented pandemic situation. The scientific
community has focused on the development of artificial intelligence (AI) algo-
rithms for the better diagnosis and prognosis of COVID-19+ patients. However,
such efforts are often performed on proprietary datasets, whereas few image
studies of patients positive for COVID-19 are publicly available.
During the first half of March 2020, the American College of Radiology
(ACR) published guidelines concerning medical imaging for COVID-19 diagno-
sis [1]. Among some of its recommendations, they include that “CT should not
be used to screen for or as a first-line test to diagnose COVID-19, CT should be
used sparingly and reserved for hospitalized, symptomatic patients with specific
clinical indications for CT”. This recommendation is in line with our initial com-
mitment to focus on conventional radiology as a tool to aid diagnosis, prognosis
and triage of COVID-19 patients.
The BIMCV COVID-19+ dataset is a large and open multi-institutional
data-bank to provide the open scientific community with data of clinical-scientific
value that helps early detection and evolution of COVID-19. Given the current
COVID-19 pandemic, both speed and efficiency in developing accurate medi-
cal solutions are key factors so that they can reach the clinical environment in
the shortest possible time. Making the information accessible to the scientific
community worldwide will undoubtedly maximize the usefulness of the data.
Some well-known examples of the scope and benefit of open access medical
datasets are:
• Pan-cancer Atlas (TCGA) [2] of the National Cancer Institute, whose open
exploitation has been essential for the development of new treatments in
precision medicine in cancer.
• MIMIC dataset [3, 4]: MIMIC-III is a widely used and freely accessible
data set developed by the MIT Laboratory for Computational Physiology,
comprising de-identified health data associated with more than 40,000
critical care patients.
• Padchest [5] from Valencian Region Medical Image Bank (BIMCV) is one
of the largest chest radiography image data banks (hereinafter CRX),
amounting to 166,000 images tagged with all observable medical entities
along with their anatomical locations.
This dataset is intended to be incremental, therefore new images along with
their annotations will be continuously added when available. At this time (first
iteration), BIMCV COVID-19+ contains 1,380 CR, 885 DX, and 163 CT full-
resolution images from 1,311 patients.
The data provided for each study, detailed in Sec. Data Records, include
the images, anonymized DICOM metadata, anonymized radiologic reports (in
Spanish), and UMLS biomedical vocabulary unique identifiers (CUIs) associated
to each image (for example, ‘infiltrate’, ’pleural effusion’, etc.) organized in
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semantic trees. In addition, 10 images were manually annotated by a team of
radiologists with the Regions of Interest (ROI) of the findings that are related
to COVID-19.
Regarding previous COVID-19 datasets, Table 2 summarizes the main fea-
tures of the datasets published so far. First, we describe the public datasets.
Table 2: Main characteristics of the different datasets with COVID-19 infor-
mation published so far. The highlighted features are: #Imag. number of
COVID-19 images; #Pat. number of patients; Sex; Age; Diagnostics: COVID,
No (COVID), Others (pneumonia caused from other virus); Surv. information
about the patient survival; View: Patient position; #Rx: number of Rx images;
#CT: number of CT images; Rad.Rep.: Radiological Reports; Pub.: Public.
Dataset #Imag. #Pat. Sex Age Diagnostics
COVID-CHESTXRAY [6] 373 205 3 3 COVID/Others
COVID-CT [7] 349 216 3 3 COVID/No
SIRM-COVID [8] 340 85 3 3 COVID
COVID-19 RAD. DB. [9] 219 Unknown 7 7 COVID/No/Others
Private dataset [10] 1,296 Unknown 7 7 COVID/No/Others
Private dataset [11] 877 Unknown 7 7 COVID/No
Private dataset [12] 1,658 Unknown 7 7 COVID/No/Others
BIMCV COVID-19+ 5,381 1,311 3 3 COVID/No/Others
Dataset Surv. View Rx CT Rad.Rep. Pub.
COVID-CHESTXRAY [6] 3 3 10 10 3 3
COVID-CT [7] 7 7 7 349 3 3
SIRM-COVID [8] 7 3 255 85 3 3
COVID-19 RAD. DB. [9] 7 7 219 7 7 3
Private dataset [10] 7 7 7 1296 7 7
Private dataset [11] 7 7 7 877 7 7
Private dataset [12] 7 7 7 1658 7 7
BIMCV COVID-19+ 7 3 3,141 2,239 3 3
COVID-CHESTXRAY [6] is a public dataset of pneumonia cases with chest
X-ray or CT images, specifically COVID-19 cases as well as MERS, SARS,
and ARDS. Data are collected from public sources in order not to infringe
patient confidentiality, and contains data from 205 patients. COVID-CT [7] is
a CT public dataset. Images are collected from COVID-19 related publications,
extracting them directly from papers in PDF format. Therefore, the quality of
images is not optimal. The number of patients is similar to the previous one.
SIRM-COVID [8] is a dataset of COVID-19 cases with RX and CT images.
It only contains positive cases, and it includes both radiological and clinical
reports. COVID-19 RADIOGRAPHY DATABASE [9] is published in Kaggle
and contains a large number of normal Rx (1,341) and other viral pneumonia
images (1,345). However, it contains few COVID-19 positive images.
There are also some private datasets. In [10], authors describe a non-public
dataset that contains a large number of CT images along with 1,735 samples
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for community acquired pneumonia and 1,325 for non-pneumonia. Another
private CT dataset in described in [11]. In this case, it contains 877 COVID-
19+ images and 541 COVID-. Finally, [12] also has a private CT dataset, with
1,659 positives and 1,027 with community acquired pneumonia.
In summary, to the best of our knowledge, BIMCV COVID-19+ is the first
dataset that includes radiological findings. In addition, it is the only COVID-19
bank in which some images are labeled with Regions of Interest (ROI) anno-
tated by radiologists. Moreover, it is the largest dataset in number of images
and patients, and it includes multiple samples for each patient to analyze their
clinical evolution. The dataset is intended to be incremental and it will grow
when as soon as images will be available. This work describes the dataset at its
first iteration (version 1), with release date 28/05/2020.
Methods
This section addresses the methodology used to produce the data. We also de-
scribe the ethics involved the process of data acquisition, the data anonymiza-
tion, and the labeling process.
Ethics statement
The Institutional Review Board (IRB) of the Miguel Hernandez University
(MHU) approved this HIPAA-compliant retrospective cohort study. The study
was approved by the local institutional ethics committee CElm: 12/2020 in Ar-
nau de Vilanova Hospital in Valencia Region. The healthcare authorities of the
Comunitat Valenciana authorized the publication of the open database based
on different reports that had to be written, among them the following should
be highlighted: A favorable report from the Data Protection Officer (DPO). A
development report of a Impact study. PIs confidentiality agreement. A confi-
dentiality agreement between researchers. The declaration of a data protection
officer for all participating entities. Compliance report of security measures
proposed in the DPO report and finally a detailed risk study together with
mitigation measures of detected risks.
Data acquisition
For data acquisition, we follow the process described in [13]. R & D Cloud
CEIB has four general modules: Search engine (SE), manager of clinical trials
(GEBID), anonymizer (CEIBANON) and BioImage Knowledge Engine (BIKE).
The technology used in R & D Cloud CEIB is completely based on Open Source.
All consecutive studies of patients with at least one positive PCR test or
positive immunological tests (IgM, IgG or IgA) for SARS-Cov-2 in the period
of time between February 26th and April 18th, 2020 were identified by querying
the Laboratory Information System records from the Health Information Sys-
tems in Comunitat Valenciana. All medical images acquired for such subjects
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in the period of time were included into the BIMCV COVID-19+ dataset. The
images included chest x rays (both digital DX and digitalized film CR), as well
as computed tomography scans CT. The images were retrieved from the Vendor
Neutral Archive (VNA) in the central medical image repository of Digital Med-
ical Image Management project (GIMD) that belongs to the public healthcare
system in the Valencian Region (Spain). The data in its first iteration were
obtained from 11 hospitals from the Valencian Region.
Data Geo-positioning
The Valencian health system is arranged in health departments, which are equiv-
alent to the health areas provided in the General Health Law. The health
departments are the fundamental structures of the Valencian health system,
being the geographical demarcations into which the territory of the Valencian
Region is divided for health purposes and constituting the framework for the
integration of health promotion and protection actions, prevention and cure and
rehabilitation of health status; through the coordination of existing resources
and guaranteeing health without steps.
In Figure 1, we show the choropleth map with the number of tests performed
(CR, DX and CT) by the health departments. In this first iteration of the
dataset it can be observed that most of the departments (11 concretely) are
from the province of Alicante and Castellón. For future iterations it is planned
to complete the map.
Data anonymization
The Organic Law 3/2018 [14] establishes the legal framework for data protection
in biomedical research. Reuse of personal data for medical research needs to be
approved by an ethics committee, and data must be at least pseudonymized
before the researchers get access. In this sense, anonymization is defined as
“the result of the processing of personal data to irreversibly prevent its identi-
fication”. That is why anonymization in itself constitutes additional processing
of personal data. Within this complex and sensitive framework, state-of-the-
art anonymization techniques in Medical Imaging have been applied to BIMCV
COVID-19+ dataset. The anonymization process is performed in two ways.
First, all references to patient data were removed from the radiological report
by using the methodology explained in [15]. This method is designed to parse
Spanish reports. It uses a pre-trained Bidirectional LSTM to identify names
and personal data and remove them from the report.
Second, DICOM anonymization was performed based on DICOM PS3.15
Annex E using a CTP [16] server. Finally, the images were evaluated in a semi-
automatic process and some of them were visually inspected to remove or crop
the burnt-in personal information from the chest x-ray images.
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Figure 1: Choropletic map with #CR #DX #CT from first iteration. https:
//maigva.github.io/maps/HealthDepartCOVID19.html
Radiological reports anonymization
Anonymization of radiological reports was performed by applying the DisMed
methodology based on a Named Entity Recognition (NER) strategy, that is
focused on the extraction and location of seven predefined entities or categories
(see Table 3) belonging to radiological reports and with a set-up of this system
to be adapted to the domain of medical texts.
Figure 2: Conceptual scheme of radiological report anonymization.
DICOM anonymization
The DICOM standard has already defined the framework that guarantees safe
access, exchange and processing of medical data. However, to the best of our
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Table 3: Name Entities selected for anonymization and their associated Pro-
tected Health Information categories.
NEs Description PHIs
CAB Section headers
NAME Names and surnames (patient and oth-
ers)
Names
DIR Full addresses, including streets, num-
bers and zip codes
Geographic data
LOC Cities, inside and outside addresses Geographic data
NUM Numbers or alphanumeric strings that
might identify someone, including dig-
ital signatures, patient numbers, med-
ical numbers, medical license numbers
and others
Medical record numbers,
social security num-
bers, account numbers,
any unique identifying
number or code
FECHA Dates Dates
INST Hospitals, health centers or other insti-
tutions
knowledge there are no tools that implements all the confidentiality profiles
defined in Part 15 of the DICOM standard [16, 17] in paragraph E ’Attribute
Confidentiality Profiles’, with the exception of the Clinical Trial Processor (CTP
[18]). To avoid compromising data privacy, it is considered crucial to implement
different modules and scripts within the CTP that will compose the development
of the ten DICOM confidentiality profiles that are defined in the standard.
For each module, the scripts related to the Basic Profile have been applied,
which is the strictest and that eliminates all the information related to (i) the
identity as well as the identifying and demographic characteristics of the pa-
tient, (ii) the identity of the authors, responsible or relatives, (iii) the identity
of any personnel involved in the procedure, (iv) the identity of the organiza-
tions involved in ordering or carrying out the method, (v) the information (not
related to the patient) that could be used to find out the identity of the original
anonymized files (for example, UID, date and time), and (vi) private attributes
(which are not part of the standard).
The system allows different types of anonymity, from the alteration of the ex-
isting text information in DICOM headers up to image-level deformation of parts
that can identify the patient (especially in neuroimaging obtained by magnetic
resonance). In the case of RX/DX/CT, no image deformations were necessary
since the reconstruction of the patient data is not possible from this information.
Image preprocessing
Raw pixel data was extracted from the DICOM images and stored into files in
nii.gz format. The images were processed by rescaling the dynamic range using
the DICOM window width and center, when available and stored as 16-bit PNG
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images. The images were not re-scaled to avoid resolution loss.
The information on image projection was estimated using a neural network
with an EfficientNet [19] architecture. The projection estimation network was
trained with 2, 000 images from Padchest [5] to whom the orientation had been
manually estimated. The projection was oversimplified to frontal (including
antero-posterior and postero-anterior) and lateral (L). No difference was made
between erect, either standing or sitting or decubitus. No difference was made
between left lateral or right lateral. Such information could be infered posteri-
orly by a careful analysis of the DICOM tags.
Labeling
The early detection and location of lesions such as infiltrates, in particular
ground glass opacities, is essential both for diagnosis and to predict the evolution
of the patient and to help taking clinical decisions. The findings that suggest a
COVID-19 infection are both the ground-glass opacity and consolidation that,
even in the initial stages, affect both lungs, particularly the lower lobes, and
specially the posterior segments, with a peripheral and subpleural distribution
mainly [20, 21, 22, 23].
These findings were present in 44% of patients in the first two days on chest
CT scans [20], in 75% of patients in the first four days [21] and in 86% of patients
during illness days 0-5 [22].
These lesions can progress in the following days until they become more
diffuse. If associated with septal thickening, they will have a reticular pat-
tern. In general, they progress both in extension and towards consolidation
concomitantly with the ground glass pattern, and may then present a rounded
morphology. It is very rare that it associates lymphadenopathy, cavitation or
pneumothorax, as did the respiratory syndrome coronavirus MERS-CoV [24].
Therefore, beyond labeling an image as COVID/No/Others like most exist-
ing datasets, it is very important to annotate the radiological findings, both for
the diagnosis and for the prognosis. It should be considered that these char-
acteristic lesions frequently appear in non-COVID patients and, on the other
hand, many COVID-19 patients do not have these lesions. The appearance of
the lesions is related to the level of the disease. It is characteristic that many
of the patients worsen and that lesions appear or become more evident.
To the best of our knowledge, BIMCV COVID-19+ is the first COVID-19
dataset that includes these findings. In addition, in this first iteration, ten
images are also annotated with the ROIs of the findings.
Assigning CUI labels to images
Clinical reports were used as a basis to obtain the radiological finding, differen-
tial diagnosis and localization labels. Therefore, images were not used in this
process.
In order to obtain the labels, the same procedure used to build PadChest [5]
was carried out, but adding to the set of labels the COVID-19 (CUI C5203670)
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and COVID-19 uncertain (CUI C5203671) labels, totaling to 336 different labels.
After a preprocessing stage in which the words from the radiological report were
stemmed and tokenized, labels were automatically extracted using a deep neural
network multi-label classifier trained with the PadChest dataset. The network
topology is detailed in [5], but it was re-trained with the additional COVID-19
labels.
More specifically, this classifier consists of a bidirectional LSTM with at-
tention mechanism that receives as input a preprocessed radiographic report
encoded as a sequence of pre-trained word-embeddings, and outputs the more
likely labels. Labels corresponding to diagnoses, radiological findings and anatom-
ical localizations, are mapped onto the UMLS controlled biomedical vocabulary
unique identifiers (CUIs) and organized into semantic concept trees.
For example, consider the following report sentence: Cambio pulmonar crónico
severo. Signos de fibrosis bibasal. Sutil infiltrado pseudonodular milimétrico en
vidrio deslustrado localizado en bases. Cifosis severa.
In this case, the neural network would outputs the following labels: [’pul-
monary fibrosis’, ’chronic changes’, ’kyphosis’, ’pseudonodule’, ’ground glass
pattern’], along with their localizations when available: [[’pulmonary fibrosis’,
’loc basal bilateral’], [’chronic changes’], [’kyphosis’], [’pseudonodule’, ’ground
glass pattern’, ’loc basal’]].
An example PadChest semantic concept sub-tree of some lesions that are
frequently associated with COVID-19 is shown next:
infiltrates [CUI:C0277877]
interstitial pattern [CUI:C2073538]
ground glass pattern [CUI:C3544344]
reticular interstitial pattern []
reticulonodular interstitial pattern [CUI:C2073672]
miliary opacities [CUI:C2073583]
alveolar pattern [CUI:C1332240]
consolidation [CUI:C0521530]
air bronchogram [CUI:C3669021]
air bronchogram [CUI:C3669021]
As it can be seen, although the radiological reports are provided in Spanish,
labels are mapped onto biomedical vocabulary unique identifier (CUIs) codes,
thus making the dataset usable regardless of the language.
In addition to the PadChest labels that can be found in [5], the new “COVID-
19” and “COVID-19 uncertain” labels were added as new terms, to denote high or
low suspicion of COVID-19 respectively. For this end, the word-embeddings of
these new labels were pre-computed in the corpus of new reports from COVID-
19 patients added to the Padchest Spanish report corpus. Then, the Padch-
est multi-label text classifier was trained with the manually labeled reports
from Padchest but adding 724 new manually annotated sentences (428 from
the BIMCV COVID-19 positive partition and 296 from the BIMCV COVID-19
negative partition) referring to COVID-19 as highly likely, uncertain or negated
based on the radiologist judgment, totaling up to 23,439 manually annotated
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Figure 3: Example annotation at pixel level. In blue, consolidation, red marks
ground glass.
sentences.
Annotation of regions of interest
Since some lesions such as infiltrates, ground glass opacities or consolidation
patterns are the most frequent in COVID-19 patients, a sub-set of 10 images
were annotated with their regions of interest (ROI) by a team of eight radi-
ologists from the Hospital Universitario de San Juan de Alicante, for the first
iteration of COVID-19 dataset.
As it can be seen in Figure 3, ROIs corresponding to these findings were
labeled at a pixel level using XNAT OHIF Viewer [25]. OHIF is a zero-footprint
medical image viewer provided by the Open Health Imaging Foundation that
stores an XML output with the ROI paths. This information is very valuable
to train semantic segmentation networks such as UNet [26] in order to extract
characteristics like the extension and exact location of the lesions. Table 4 shows
the findings that are annotated at a ROI level.
Code availability
The annotation pipeline from medical reports including their text preprocessing
and the multi-label classifier based on bidirectional Long Short-Term Memory
Networks (LSTM) with attention mechanism is available at https://github.
com/auriml/Rx-thorax-automatic-captioning.
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Id Description
1 Ground glass XRays
2 Consolidation XRays
3 Peural effusion XRays
4 Interstitial RX
5 Ground glass CT
6 Crazy Paving CT
7 Inverted halo CT
8 Vascular thickening (in ground glass region) CT
9 Ground glass and consolidation focus CT
10 Nodular consolidation or in CT
11 Normal consolidation CT
12 Sprouting tree pattern CT
13 Pleural effusion CT
14 No RX or TAC findings
Table 4: Findings that are annotated with their ROIs using XNAT OHIF
Viewer.
Database analysis
Statistics about the dataset were acquired with a python Jupyter notebook
available at https://github.com/BIMCV-CSUSP/BIMCV-COVID-19.
Data Records
The BIMCV (Medical Imaging Bank of the Valencia Region) specializes in col-
lecting and organizing data imaging information to facilitate the research in
artificial intelligence and big data with medical imaging. The BIMCV team
has designed MIDS (Medical Imaging Data Structure)1, a standard to organize
every type of medical information and images in simple hierarchy folders. MIDS
constitutes an extension of the standard BIDS (Brain Imaging Data Structure),
that is a structure that collects medical resonance brain images (MRI) and is
described in [27]. MIDS intends to expand BIDS, extending its usage to any
type of medical imaging modality and anatomical area of the body instead of
only medical brain images.
The main goal of MIDS is to define a standard for organization and descrip-
tion of the medical imaging datasets in the field of artificial intelligence and
to facilitate data sharing. For this, we have adapted DICOM standard in an
hierarchical organization that will be based on folder organization with simple
file formats (TSV and JSON). The main data types for Imaging are: nifti (3D)
or png (2D) files; for phenotypic data, Tab Separated Value files (.tsv); and for
metadata information (Key/value dictionaries), JSON files.
1https://github.com/BIMCV-CSUSP/MIDS
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Figure 4: MIDS structure for BIMCV COVID-19+ dataset. (A) Conceptual
schema (B) General Template (C) Example of folder structure.
Figure 4 shows an example from BIMCV COVID-19+ data structured in
MIDS format. The data provided for each sample is described next:
Diagnostic tests: All the diagnostic tests performed to each individual
to diagnose COVID-19. The diagnostic test could be PCR, IGG or IGM. The
result of the test can be positive, negative or indeterminate. A subject can have
several tests during the period of time with different outcomes. The list of tests
is stored into the file sil_reg_covid.csv.
Radiological reports: The radiological reports for each image study per-
formed to the subject anonymized as explained in Section Radiological reports
anonymization. They are included in the file
derivatives/EHR/labels/labels_COVID-19_posi.tsv.
CUI disease and location terms: extracted automatically using the
methodology described in Subsection Labeling. They are stored in the same file
than the radiological reports.
CUI hierarchy: a tree description of the CUI hierarchy used to describe
the diseases. File
derivatives/EHR/labels/tree_term_CUI_counts_image_covid_posi.csv.
Image data: Each subject can have a plurality of image studies, also called
sessions, performed on the period of time of the observation. Each image study
has a plurality of image series. They are all stored in the directory structure
depicted in Fig. 4. Image data is extracted from the DICOM images and stored
in .nii.gz. The relevant DICOM fields for each image series are stored in a JSON
file with the same name than the image series.
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Technical Validation
The data collected contains 1,311 subjects, 2.429 image studies and 5,530 image
series. 602 patients were female (45.92%). The mean age was of 63.11 (± 16.75).
The histogram of their age is shown in Fig. 5 (top) and is highly coherent with
the demographics of COVID-19+ in Spain.
There is an average of 1.9 image studies per subject. The distribution can be
seen in Fig. 5 (middle). With respect to image modality, the dataset contains
1,380 CX, 885 DX and 163 CT studies. 2,427 chest x-rays were acquired in
monochrome 2 photometric interpretation and 751 in monochrome 1. Images in
monochrome 1 should be inverted for their proper visualization. The vendors of
the devices used to acquire the studies are shown on Table 5. As can be seen,
there are different acquisition systems, which ensures variability in the dataset
images.
Manufacturer and model #studies
KONICA MINOLTA 0862 342
GMM ACCORD DR 255
SIEMENS SIEMENS FD-X 247
Agfa DR 14e C - 1200ms 161
Agfa DX-M 161
"GE Healthcare" "Thunder Platform" 150
Philips Medical Systems DigitalDiagnost 133
Philips Medical Systems PCR Eleva 113
Agfa 3543EZE 112
Carestream Health DRX-1 87
KONICA MINOLTA CS-7 77
SIEMENS SOMATOM go.Up 69
Agfa Pixium_4343E_CSI 59
Agfa CR30-X 39
Canon Inc. CXDI Control Software NE 37
TOSHIBA Aquilion 36
Philips DigitalDiagnost 34
KONICA MINOLTA 0110 23
Philips Brilliance 16 23
Philips Medical Systems Essenta DR 21
Table 5: Number of studies acquired by each device for devices with more than
15 studies acquired.
A total of 2,425 PCR tests have been performed on the patients, from which
1,773 resulted positive for SARS-Cov-2, 622 negative for SARS-Cov-2 and 30
indeterminate, 29 IGM 29 IGG and 35 ACT tests were performed, being 44
positive, 32 negative and 17 indeterminate. The average closest time between
an image and a diagnostic test is 5.03 days, being the distribution as shown in
Fig. 5 (bottom). Please note that some images have a diagnostic test as far
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Figure 5: Top: histogram of the patients age. Middle: histogram of the number
of studies per subject. Bottom: histogram of the difference (in days) between
the image study and the diagnostic test. Please note that most of the studies
have less than five days between the radiography and the diagnostic test.
as 50 days afterwards. Such is acceptable, since the period of observation is of
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two months and there are image studies performed to the subjects prior to their
COVID-19 diagnosis.
135 studies were deemed suboptimal in the radiology reports. The most
common radiological findings on the images, as well as the number of their
appearances, are shown in Table 6. Due to the construction of the database,
COVID-19 appears as the most common radiological finding, followed by den-
sities, pneumonia, consolidations and infiltrates, all findings closely related to
COVID-19.
Image anonymization was validated by visually inspecting all the cropped
images to verify that no data from the patients was displayed.
Chest x-ray images were manually inspected to validate if the patient ori-
entation was correctly estimated with the neural network described in Section
Image Preprocessing. The orientation was changed in case it was mistakenly
estimated.
Radiological finding and diagnosis Number
COVID 19 802
increased density 657
pneumonia 605
unchanged 494
consolidation 357
infiltrates 346
interstitial pattern 317
alveolar pattern 291
normal 284
ground glass pattern 240
cardiomegaly 166
pleural effusion 149
laminar atelectasis 88
costophrenic angle blunting 83
suboptimal study 82
viral pneumonia 62
endotracheal tube 59
aortic elongation 58
nodule 54
central venous catheter 54
Table 6: Radiological findings and diagnoses extracted from the radiology
reports when having more than 50 appearances.
Regarding the labeling of the reports, in some of them where the text
“COVID-19” was mentioned those mentions were actually negated expressions
for COVID-19 disease based on image. The neural network was trained to ensure
that the model could detect these COVID-19 denials and validate that the labels
“COVID-19” and “COVID-19 uncertain” were correctly extracted. The model
achieved an F1-micro of 0.922 on the validation set with 2,343 manually labeled
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Figure 6: ROIs marked for 10 images from different series. Green: ground glass
opacities. Purple: consolidations.
sentences (which includes sentences from Padchest [5], BIMCV COVID-19 pos-
itive and BIMCV COVID-19 negative partitions), and it was further validated
using an independent test sample.
This independent test sample consisted of 64 new sentences manually la-
beled and randomly extracted from the BIMCV COVID-19 negative partition
in which the text COVID-19 was mentioned. In some cases the mention was
to deny it (24), in others it is to denote low suspicion based on image findings
because of atypical findings “COVID 19 uncertain” (13) and in the rest (27) it
was affirmatively mentioned because the image was compatible with COVID-19
even if those studies were included in the BIMCV-COVID-19 negative samples.
Results on this experiment are shown in Table 7.
Radiological findings set Precision Recall F-Score
COVID-19 0.961 0.925 0.943
COVID-19 uncertain 1.0 0.846 0.916
Table 7: Classification results in an independent sample test of the COVID-19
labels
In addition, the method was evaluated for all included entities, both those en-
tities related or not related to COVID-19 pneumonia, on the same independent
test set, using the metrics described in [5], obtaining an F1-weighted=0.9320,
F1-micro=0.9378, and accuracy=0.8281.
Usage Notes
This dataset offers valuable information for professionals, for example to train
radiologists on this new pathology and understand the lesions that can be typ-
ically found. In addition, it serves to train deep learning methods with the
images and labels in order to assist radiologists in the decision-making process.
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Figure 7: Longitudinal series for the same subject with 15 image studies between
March 14th and March 30th 2020.
The data can be downloaded under request from the BIMCV web page
(http://bimcv.cipf.es/bimcv-projects/bimcv-covid19). Is is freely avail-
able for research, and can also be used for commercial purposes under cer-
tain conditions. Before downloading the data, the user should accept the End-
User License Agreement detailed in http://bimcv.cipf.es/bimcv-projects/
bimcv-covid19/bimcv-covid19-dataset-research-use-agreement-2/.
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